Biotechnology markets include the tools, consumables, services and intellectual property necessary for life sciences and applied medical research. The products of such research include biopharmaceuticals, vaccines, and other biologics. Emerging markets like that of mass spectrometry used in clinical testing applications highlight technological advances that urge more companies to make deals in the field of biotechnology. As the industry grows, companies will develop and integrate automated platforms and diagnostic kits that greatly increase convenience and reliability. This efficiency-mindedness had permeated the past decade in the biotechnology field, as the pace and breadth of translational or biomedical research has created multi-billion dollar markets for research tools and services as well as for the discovered and subsequently marketed biologics. In the future, companies hope to see convenient clinical diagnostic applications eventually coming into multiple areas of the clinical lab.
Next Generation Sequencing
Proteomics
Biopharmaceuticals
Instrumentation & Equipment
Emerging Technologies
- Display 15 Products per page
Published: March 1, 2003 | Price: $250.00 – $5,250.00
The world of analytical microchips is the fastest growing technology segment in the life sciences today. The range of applications to which these miniature laboratories may be directed is very broad--covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. Where chips were initially envisioned as carriers of microscopic binding sites...Published: July 1, 2003 | Price: $2,625.00 – $5,250.00
In today's world of Orthopedic Biomaterials, one thing that is expanding rapidly is the amount of new products in the research pipeline: stem cells, bone growth factors, gene therapy, synthetic bone fillers, bioactive implant coatings and biopolymers among others. The overall market is expected to enjoy healthy growth over the next 5 years, but the number one expansion story is in the bone growth factors and proteins segment, so called orthobiologics. These products could grow from just a few percent...Published: March 1, 2004 | Price: $3,500.00 – $7,000.00
Cell and tissue therapies are about to revolutionize the treatment of a number of diseases, including: organ, replacement, cartilage, skin, autoimmune diseases, diabetes, neurodegenerative diseases, cancer and cardiovascular tissue damage. Although cell therapy is not a new phenomenon, what is new is the scope and versatility of research using stem cell and tissue therapeutics, and products based on combinations of cell therapy, gene manipulation, and tissue engineering. The report provides world market projections 2002-2007, discusses market trends and issues including...Published: June 1, 2004 | Price: $3,500.00 – $7,000.00
In 2003, the market for monoclonal antibodies in the treatment of cancer is just short of $2.8 billion and growing at a phenomenal rate. The market is fueled by leading products such as Rituxan and Herceptin; however, other products continue to demand more attention each year. This study reviews market data for the years 2001 to the present and forecasts the market to 2008, including Kalorama’s estimates of the competitive market share in 2008 based on the current pipeline and...Published: August 1, 2004 | Price: $3,500.00 – $7,000.00
This Kalorama Information report focuses on current and emerging immunomodulators for cancer. The report covers both current and emerging cancer immunomodulators in detail. The report includes statistical information for cancers by type worldwide, with special emphasis on the U.S. market. Specifically, cancers where there are current products available or are in development are profiled. These include bladder, breast, colorectal, head/neck, kidney, lung, ovarian, pancreatic, and prostate cancers, as well as leukemia, lymphoma, melanoma, multiple myeloma, and neuroblastoma. The current market...Published: September 1, 2004 | Price: $895.00 – $1,790.00
Nanotechnology is no longer a bench-top curiosity. It is becoming a real commercial force for a variety of applications. This market briefing discusses the state of play in the race to commercialize products and forecasts likely market scenarios. The briefing forecasts the market in generally promising areas such as cancer therapeutics, specialized drug delivery, diagnostics, and topical therapies, reviewing what companies are doing in those markets.Published: June 1, 2005 | Price: $3,500.00 – $7,000.00
Analytical microchips continue to be among the fastest growing technology segments of the life sciences. The range of applications to which these miniature laboratories may be directed is very broad, covering fields as different as pharmaceutical development, food testing, clinical diagnostics, forensics, and environmental analysis. Moreover, while the number of such products is currently limited, the number of applications is rapidly expanding through the development of significant enabling technologies. This completely updated 2nd edition of Kalorama’s popular 2003 study thoroughly...Published: September 1, 2005 | Price: $795.00 – $1,590.00
One of the keys to understanding many complex biological interactions, is the role played by specific carbohydrates. This is glycobiology. While many glycobiology-related products commercialized to date are detection and analysis kits for analyzing glycoproteins and the extent of glycosylation, a newer body of research is harnessing glycobiology to develop glycol-based drugs, or glycotherapeutics. The glycosylated therapeutics business is among the faster growing segments in the drug industry, but the development of novel glycosylated therapies is only in the early...Published: January 1, 2006 | Price: $2,995.00 – $5,990.00
The field of biotechnology instrumentation has been an expanding one ever since the emergence of the Human Genome Project 20 years ago. Although the filed certainly existed prior to that point in time, it was the Human Genome Project with its major access to key universities, national laboratories, and government funding sources that gave great acceleration to the field. There are several technologies applicable to genomic and proteomic analysis, all of which have become important to the nature of the...Published: June 1, 2006 | Price: $995.00 – $7,800.00
The protein therapeutics sector is a story of triumphant science, representing both life-saving treatments for millions and a multi-billion dollar industry. This report details both the scientific and business aspects of the protein therapeutics marketplace, including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to 2010 for each of the following individual product areas: Monoclonal Antibodies Erythropoietins Insulin Interferons Growth Factors Interleukins Blood Clotting Factors Tissue Plasminogen Activator Human Growth Hormones Reproductive Hormones Recombinant BMP-2...Published: November 1, 2006 | Price: $995.00 – $5,990.00
Protein biomarkers have become the hot application area for mass spectrometry (MS) and other proteomics-related technologies in the last few years. In the short term, this move towards biomarkers and clinical proteomics research has happened mainly in the drug discovery and development process. However, they also have broad abilities to generate richer information about a disease state, drug response, and/ or the relation between the two; which can be used for diagnostic, prognostic, or various other purposes in the pharmaceutical,...Published: January 1, 2007 | Price: $995.00 – $3,990.00
Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials. Anyone looking to take advantage of the opportunities the market for biomarker research offers will find Kalorama’s Biomarkers: A Market Briefing an essential study of this emerging market. Not only...Published: January 1, 2007 | Price: $3,900.00 – $7,800.00
As the biopharmaceutical market grows, so will the cell culture products market. Cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. This report is focused on cell culture used in the research and...Published: May 1, 2007 | Price: $995.00 – $3,990.00
Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But over the next five years, treatment is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market from Kalorama Information. One of the most promising new approaches in modern cancer treatment is immunotherapy, the development of methods to augment and enhance the...Published: July 1, 2007 | Price: $2,995.00 – $5,990.00
2008 has seen no decrease in attention on wound care products. The aging of the population and a constant demand for products that speed healing and improve outcomes drives the wound care industry. For market watchers, this makes for a dynamic market that has changed in recent years with biological developments. Kalorama Information's analyst Mary Ann Crandall has reviewed the Wound Care Industry in several editions of wound care market reports and has participated in industry panels. Kalorama Information's three-volume...